Neostigmine Methylsulfate PF Inj — Class III drug recall D-0175-2021
Terminated recall by US Compounding Inc, reported 2021-01-06, distributed nationwide. Labelling: Missing label.
| Recall number | D-0175-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | US Compounding Inc, Conway, AR, United States |
| Recall initiated | 2020-11-25 |
| Classified | 2020-12-29 |
| Reported by FDA | 2021-01-06 |
| Terminated | 2021-11-05 |
| Distributed | Nationwide (US) |
| Quantity | 1,640 syringes |
| Reason classes | labeling |
| NDC | 62295-3324-05 |
| Expiration dates | 2021-03-20 |
Product
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05
Reason for recall
Labelling: Missing label.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0175-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.